These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35114969)

  • 21. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC; Mutembo S; Matakala KH; Chilumba I; Mulundu G; Monze M; Mwansa FD; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2021 May; 104(6):2229-2232. PubMed ID: 33939639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post-vaccination campaign coverage evaluation of oral cholera vaccine, oral polio vaccine and measles-rubella vaccine among Forcibly Displaced Myanmar Nationals in Bangladesh.
    Khan AI; Islam MT; Siddique SA; Ahmed S; Sheikh N; Siddik AU; Islam MS; Qadri F
    Hum Vaccin Immunother; 2019; 15(12):2882-2886. PubMed ID: 31441679
    [No Abstract]   [Full Text] [Related]  

  • 24. Social capital, trust in health information, and acceptance of Measles-Rubella vaccination campaign in Tamil Nadu: A case-control study.
    Palanisamy B; Gopichandran V; Kosalram K
    J Postgrad Med; 2018; 64(4):212-219. PubMed ID: 29943738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.
    Murhekar MV; Gupta N; Hasan AZ; Kumar MS; Kumar VS; Prosperi C; Sapkal GN; Thangaraj JWV; Kaduskar O; Bhatt V; Deshpande GR; Thankappan UP; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma S; Sarmah NP; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Shrivastava AK; Chonker SK; Tilekar B; Tandale BV; Ahmad M; Sangal L; Winter A; Mehendale SM; Moss WJ; Hayford K
    Lancet Glob Health; 2022 Nov; 10(11):e1655-e1664. PubMed ID: 36240831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trend of measles-rubella vaccination coverage and impact on measles epidemiology in the Savannah Region, Ghana; 2018-2022: A secondary data analysis.
    Rockson Adjei M; Longsignikuu A; Saeed Iddris I; Nang Suuri T; Asamoah B; Okoye M; Vanessa Baafi J; Kubio C; Ohene SA; Grobusch MP
    Vaccine; 2024 Mar; 42(8):1910-1917. PubMed ID: 38365480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.
    Kainga HW; Ssendagire S; Ssanyu JN; Nabukeera S; Namuhani N; Mangen FW
    PLoS One; 2021; 16(1):e0243137. PubMed ID: 33428640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
    Mak J; Patenaude BN; Mutembo S; Pilewskie ME; Winter AK; Moss WJ; Carcelen AC
    Am J Trop Med Hyg; 2024 Jul; 111(1):121-128. PubMed ID: 38772386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F; Magloire R; Danovaro-Holliday MC; Flannery B; Chamoulliet H; Celestin EP
    J Infect Dis; 2011 Sep; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cluster survey evaluation of a measles vaccination campaign in Jharkhand, India, 2012.
    Scobie HM; Ray A; Routray S; Bose A; Bahl S; Sosler S; Wannemuehler K; Kumar R; Haldar P; Anand A
    PLoS One; 2015; 10(5):e0127105. PubMed ID: 26010084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distributing insecticide-treated bednets during measles vaccination: a low-cost means of achieving high and equitable coverage.
    Grabowsky M; Nobiya T; Ahun M; Donna R; Lengor M; Zimmerman D; Ladd H; Hoekstra E; Bello A; Baffoe-Wilmot A; Amofah G
    Bull World Health Organ; 2005 Mar; 83(3):195-201. PubMed ID: 15798843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using geospatial models to map zero-dose children: factors associated with zero-dose vaccination status before and after a mass measles and rubella vaccination campaign in Southern province, Zambia.
    Arambepola R; Yang Y; Hutchinson K; Mwansa FD; Doherty JA; Bwalya F; Ndubani P; Musukwa G; Moss WJ; Wesolowski A; Mutembo S
    BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34969682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(44):976-9. PubMed ID: 11724151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia.
    Mutembo S; Carcelen A; Mwansa FD; Searle K; Wanyiri JW; Book C; Thuma PE; Moss WJ; Hayford K
    Am J Trop Med Hyg; 2018 Dec; 99(6):1639-1642. PubMed ID: 30277204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation and evaluation of a measles/rubella vaccination campaign in a campus university in the UK following an outbreak of rubella.
    Stevenson J; Murdoch G; Riley A; Duncan B; McWhirter M; Christie P
    Epidemiol Infect; 1998 Aug; 121(1):157-64. PubMed ID: 9747767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B; Balasegaram S; Gobin M; Anderson C; Charlett A; Coole L; Maguire H; Nichols T; Rawlings C; Ramsay M; Oliver I
    Vaccine; 2014 Aug; 32(36):4681-8. PubMed ID: 24996125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost of conducting Measles-Rubella vaccination campaign in India.
    Chatterjee S; Song D; Das P; Haldar P; Ray A; Brenzel L; Boonstoppel L; Mogasale V
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-8. PubMed ID: 34411494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with non-uptake of measles-rubella vaccine second dose among children under five years in Mtwara district council, Tanzania, 2017.
    Magodi R; Mmbaga EJ; Massaga J; Lyimo D; Mphuru A; Abade A
    Pan Afr Med J; 2019; 33():67. PubMed ID: 31448029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.